Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: A large single-center experience

Transplantation Proceedings

Volumn 45, Issue 4, 2013, Pages 1491-1496

  Slatinska, J ^a   Rohal, T ^a   Wohlfahrtova, M ^a   Viklicky, O ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ANEMIA; ANGINA PECTORIS; BK VIRUS INFECTION; CATARACT; CHOLECYSTITIS; COLITIS; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENTERITIS; ESOPHAGITIS; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; HYPERTENSION; ILEUS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEG THROMBOSIS; LEUKOPENIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEOPLASM; NON SKIN NON LYMPHOMA; PEPTIC ULCER; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PRURITUS; SIDE EFFECT; SKIN CARCINOMA; THROMBOTIC THROMBOCYTOPENIC PURPURA; URETHRA STENOSIS; URINARY TRACT INFECTION; VASCULAR DISEASE; VERRUCA VULGARIS; WOUND HEALING IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; DELAYED-ACTION PREPARATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; YOUNG ADULT;

EID: 84878612241     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.11.017     Document Type: Conference Paper

References (21)

1. S.A. Cross, C.M. Perry Tacrolimus once-daily formulation in the prophylaxis of transplant rejection in renal or liver allograft recipients Drugs 67 2007 1931 1943
2. L.C.P. Borra, J.I. Roodnat, J.A. Kal High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation Nephrol Dial Transplant 25 2010 2757 2763
3. P. Trunecka, B. Boillot, D. Seehoferc Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation Am J Transplant 10 2010 2313 2323
4. B.K. Krämer, B. Charpentier, L. Bäckman Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study Am J Transplant 10 2010 2632 2643
5. J.P. Van Hooff, R.R. Alloway, P. Trunecka Four-year experience with tacrolimus once- daily prolonged release in patients from phase II conversion and de novo kidney, liver, and heart studies Clin Transplant 25 2010 E1 E12
6. A.S. Levey, J.P. Bosch, J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
7. L.C. Racusen, K. Solez, R.B. Colvin The Banff 97 working classification of renal allograft pathology Kidney Int 55 1999 713 723
8. R. Lauzurica, J.M. Morales, J. van Hooff Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus Transplant Int 25 2012 48 55
9. H. De Jonge, D.R. Kuypers, K. Verbeke Reduced Co concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation Transplantation 90 2010 523
10. I. Kurnatowska, T. Krawczyk, T. Oleksik Tacrolimus dose and blood concentration variability in kidney transplant recipients undergoing conversion from twice daily to once daily modified release tacrolimus Transplant Proc 43 2011 2594 2596
11. M.-J. Wu, C.-H. Cheng, W.-P. Wu Lower variability of tacrolimus trough concentration after conversion from Prograf to Advagraf in stable kidney transplant recipients Transplant Int 92 2011 648 652
12. B. Krüger, B. Banas, P. Tomlinson Early post-transplant blood Levels in de novo renal recipients on tacrolimus prolonged release (TacQD) versus tacrolimus immediate-release (TacBD) in a phase III double-blind double-dummy study J Am Soc Nephrol 2010 PO3070
13. J. Sańko-Resmer, O. Boillot, P. Wolf Renal function, efficacy and safety postconversion from twice- to once-daily tacrolimus in stable liver recipients: an open-label multicenter study Transplant Int 25 2012 283 293
14. J.M. Morales, E. Varo, P. Lázaro Immunosuppressant treatment adherence, barriers to adherence and quality of life in renal and liver transplant recipients in Spain Clin Transplant 26 2012 369 376
15. L. Guirado, C. Cantarell, A. Franco Efficacy and safety of conversion from twice-daily to once- daily tacrolimus in a large cohort of stable kidney transplant recipients Am J Transplant 11 2010 1965 1971
16. J. Uchida, N. Kuwabara, T. Nakatani Conversion of stable kidney transplant recipients from a twice-daily Prograf to once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism Transplant Proc 44 2012 128 133
17. A. Kolonko, J. Chudek, A. Wiȩcek Improved kidney graft function from twice daily tacrolimus to a once daily prolonged-release formulation Transplant Proc 43 2011 2950 2953
18. J. Pascual, J.P. van Hooff, K. Salmela Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant Transplantation 82 2006 55 61
19. T. Tsuchiya, K. Ishida, S. ito Effect of conversion from twice-daily to once-daily tacrolimus on glucose intolerance in stable kidney recipients Transplant Proc 44 2012 118 120
20. S. Beckebaum, S. Laco, D. Sweid Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to a once-daily tacrolimus extended-release formulation Transplant Int 24 2011 666 675
21. M. Veroux, G. Grosso, B. Ekser Impact of conversion to an once-daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications Transplantation 93 2012 895 899